Lung Cancer Update cover image

Striving for Consensus on the Management of ALK-Positive Lung Cancer

Lung Cancer Update

00:00

The Evolution of Alk Rearrangements

Ross: I think as you rightly point out, it really is a very rapid evolution and Alk rearrangements were only identified in 2007. But we've had the development of first generation, second generation and now even later generation compounds. And really what we've seen is very meaningful impacts on patients in terms of outcomes and even survival with with these newer inhibitors. So I actually think the beginning of personalized therapy, really, the world shattered without. Absolutely.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app